Patent No. EP3542790 (titled "Compositions Comprising A Delivery Agent And Preparation Thereof") was filed by Novo Nordisk on Mar 15, 2013. The application was issued on Sep 13, 2023.
A pharmaceutical formulation comprising a granule comprising a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant, wherein the granule is manufactured by dry granulation and obtained by mixing said salt of N-(8-(2-hydroxybenzoyl)amino)caprylic and said lubricant for more than 5 minutes prior to dry granulation and wherein the composition comprises one or more intragranular part(s) and an extra-granular part and wherein the intragranular part(s) have been granulated, and wherein the extragranular part has been added after granulation.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents